Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Lenalidomide Has Positive Benefit/Risk Ratio, Says EMALenalidomide Has Positive Benefit/Risk Ratio,
Link ID 37698
Title Lenalidomide Has Positive Benefit/Risk Ratio, Says EMALenalidomide Has Positive Benefit/Risk Ratio,
Url http://www.medscape.com/viewarticle/750306?src=rsshttp://www.medscape.com/viewarticle/750306?src=rss
Description The benefit/risk balance for lenalidomide remains positive within its approved population, according to the European Medicines Agency (EMA). Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date Sep 24, 2011
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Warning: Counterfeit Bevacizumab (Avastin) in the USWarning: Counterfeit Bevacizumab (Avastin) in th
  A counterfeit product labeled Avastin that is circulating in the United States contains no active ingredient, so cancer patients might be missing out on treatment. News Alerts
Category:   Articles > Hematology-Oncology


2. Anti-N-methyl-D-aspartate Receptor Encephalitis
  In this video blog, Dr. Kapil Sethi discusses the etiologies, symptoms, and management of anti-N-methyl-D-aspartate (anti-NMDA) receptor encephalitis. Medscape Neurology & Neurosurgery
Category:   Articles > Hematology-Oncology


3. Confronting the Unexpected: Temporal, Situational, and Attributive Dimensions of Distressing Symptom
  Residual symptoms of pain, loss of energy, impaired limb movement, and more plague breast cancer survivors. What can be done to reduce the impact? Oncology Nursing Forum
Category:   Articles > Hematology-Oncology


4. NCCN Offers "Very Sophisticated Tools" to Patients
  The NCCN is offering guidelines for breast and lung cancer patients that look a lot like the guidelines for clinicians. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. New Therapeutic Options in CML and What They Mean for Patients: An Expert Interview With Dr. Jorge C
  In this Expert Interview from ASH 2007, Dr. Jorge Cortes discusses new and follow-up data from clinical trials of drug therapies for CML.
Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS